Day One Biopharmaceuticals (DAWN) Income Statement: Revenue & Earnings

Day One Biopharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Day One Biopharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	131.16	0.00	0.00	0.00	0.00
Cost of Revenue	5.28	0.00	0.00	0.00	0.00
Gross Profit	125.88	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	222.70	130.52	85.62	43.58	9.10
Selling, General & Administrative	115.45	75.54	61.29	29.16	4.68
Operating Expenses	338.15	206.06	146.91	72.74	13.78
Operating Income	-212.27	-206.06	-146.91	-72.74	-13.78
Other Income/Expense
Interest Income	19.70	17.19	4.75	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	-0.03
Other Income/Expense	109.22	17.15	4.73	0.02	-30.03
Income
Income Before Tax	-88.35	-188.92	-142.18	-72.75	-43.84
Income Tax Expense	7.14	0.00	0.00	0.00	0.00
Net Income	-95.50	-188.92	-142.18	-72.75	-40.51
Net Income - Continuous Operations	-95.50	-188.92	-142.18	-72.75	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-210.71	-205.68	-146.38	-72.56	-13.77
EBIT	-212.27	-206.06	-146.91	-72.76	-13.78
Depreciation & Amortization	1.56	0.38	0.53	0.02	0.02
Earnings Per Share
Basic EPS	-1.00	-2.00	-2.00	-5.00	-7.00
Diluted EPS	-1.00	-2.00	-2.00	-5.00	-7.00
Basic Shares Outstanding	93.23	79.77	65.47	36.96	5.53
Diluted Shares Outstanding	93.23	79.77	65.47	36.96	5.53